Using total error concept for the validation of a liquid chromatography-tandem mass spectrometry method for the determination of budesonide epimers in human plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 877, Issue 23, 2009, Pages 2290-2300

  Streel, B ^a   Cahay, B ^a   Klinkenberg, R ^a  

^a Galephar MF   (Belgium)

Author keywords

Budesonide; LC MS MS; Pharmacokinetics; Solid phase extraction; Validation strategy

Indexed keywords

AMMONIUM ACETATE; ANALYTES; ATMOSPHERIC PRESSURE CHEMICAL IONIZATION; BIOLOGICAL MATRIXES; BUDESONIDE; DECISION TOOL; DISPOSABLE EXTRACTION CARTRIDGES; EPIMERS; FORMAL VALIDATION; GLACIAL ACETIC ACID; HUMAN PLASMAS; INTERNAL STANDARDS; ION TRANSITION; LC-MS/MS; LIMIT OF QUANTITATIONS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; MOBILE PHASE; OCTADECYLSILICA; PHARMACOKINETIC STUDIES; PLASMA CONCENTRATION; PRE-VALIDATION; REGRESSION MODEL; RESPONSE FUNCTIONS; RISK AND UNCERTAINTY; SELECTED REACTION MONITORING; SOLID-PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; VALIDATED METHODS; VALIDATION STRATEGY;

ACETONITRILE; AMMONIUM COMPOUNDS; ATMOSPHERIC IONIZATION; ATMOSPHERIC PRESSURE; CAPILLARY FLOW; CHROMATOGRAPHIC ANALYSIS; CHROMATOGRAPHY; DISSOLUTION; HIGH PRESSURE LIQUID CHROMATOGRAPHY; IONIZATION OF LIQUIDS; LIQUIDS; MASS SPECTROMETERS; MASS SPECTROMETRY; PHARMACOKINETICS; PLASMA (HUMAN); PLASMAS; REGRESSION ANALYSIS; SOLVENT EXTRACTION;

DRUG PRODUCTS;

BUDESONIDE; HYDROCORTISONE ACETATE;

ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; DRUG STRUCTURE; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

BUDESONIDE; CHROMATOGRAPHY, LIQUID; HUMANS; ISOMERISM; TANDEM MASS SPECTROMETRY;

EID: 67650155366     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2009.02.004     Document Type: Article

References (29)

1. Spencer C.M., and McTavish D. Drugs 50 5 (1995) 854
2. Hvizdoz K.M., and Jarvis B. Drugs 60 5 (2000) 1141
3. Wang Y., Tang Y., Moellmann H., and Hochhaus G. Biomed. Chromatogr. 17 (2003) 158
4. (Benny) Li Y.N., Tattam B., Brown Kenneth F., and Paul Seale J. J. Chromatogr. B 761 (2001) 177
5. William Kelly H. Ann. Pharmacother. 32 (1998) 220
6. Assi K.H., Tarsin W., and Chrystyn H. J. Pharm. Biomed. Anal. 41 (2006) 325
7. Hochhaus G., Fröehlich P., Hochhaus R., Möllmann A., Derendorf H., and Möllmann H.W. J. Pharm. Biomed. Anal. 17 (1998) 1235
8. Hou S., Hindle M., and Byron P.R. J. Pharm. Biomed. Anal. 39 (2005) 196
9. Gupta M., and Bhargava H.N. J. Pharm. Biomed. Anal. 40 (2006) 423
10. European Pharmacopoeia, 6th ed., Directorate for the Quality of Medicines of the Council of Europe, Strasbourg, France, Monograph 01/2008, p. 1075.
11. United States Pharmacopoeia, 307th ed., suppl. 1, Rockville, MD, USA, 2007, p. 3756.
12. (Benny) Li Y.N., Tattam B., Brown K.F., and Seale J.P. J. Chromatogr. B 683 (1996) 259
13. Kronkvist K., Gustavsson M., Wendel A.K., and Jaegfeldt H. J. Chromatogr. A 823 (1998) 01
14. Deventer K., Mikuleikova P., Van Hoecke H., Van Eenoo P., and Delbeke F.T. J. Pharm. Biomed. Anal. 42 (2006) 474
15. Hubert Ph., Nguyen-Huu J.-J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.-A., Dewe W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., and Valat L. STP Pharma Pratiques 13 3 (2003) 101
16. Chapuzet E., Mercier N., Bervoas-Martin S., Boulanger B., Chevalier P., Chiap P., Grandjean D., Hubert Ph., Lagorce P., Lallier M., Laparra M.C., Laurentie M., and Nivet J.C. STP Pharma Pratiques 7 (1997) 169
17. Hubert Ph., Chiap P., Crommen J., Boulanger B., Chapuzet E., Mercier N., Bervoas-Martin S., Chevalier P., Grandjean D., Lagorce P., Lallier M., Laparra M.C., Laurentie M., and Nivet J.C. Anal. Chim. Acta 391 (1999) 135
18. Hubert Ph., Nguyen-Huu J.-J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.-A., Dewé W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., Valat L., and Rozet E. J. Pharm. Biomed. Anal. 45 (2007) 70
19. Hubert Ph., Nguyen-Huu J.-J., Boulanger B., Chapuzet E., Cohen N., Compagnon P.-A., Dewé W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Valat L., and Rozet E. J. Pharm. Biomed. Anal. 45 (2007) 82
20. Boulanger B., Dewe W., Chiap P., Crommen J., and Hubert Ph. J. Pharm. Biomed. Anal. 32 (2003) 753
21. Boulanger B., Dewe W., Feinberg M., Laurentie M., Crommen J., and Hubert Ph. J. Pharm. Biomed. Anal. 36 (2004) 579
22. ISO 5725-1, Application of the Statistics-Accuracy (Trueness and Precision) of the Results and Methods of Measurement. Part 1. General Principles and Definitions, International Organization for Standardization (ISO), Geneva, Switzerland.
23. Shah V.P., Midha K.K., Dighe S., McGilveray I.J., Skelly J.P., Yacobi A., Layloff T., Viswanathan C.T., Cook C.E., McDowall R.D., Pittman K.A., and Spector S. Pharm. Res. 9 (1992) 588
24. Guidance for Industry: Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), May 2001.
25. Miller J.C., and Miller J.N. Statistics for Analytical Chemistry. 5th ed. (2000), Ellis Horwood, New York p. 96
26. Boulanger B., Dewe W., Gilbert A., Govaerts B., and Maumy-Bertrand M. Chemometr. Intell. Lab. Syst. 86 (2007) 198
27. Analytical Methods Committee. Analyst 120 (1995) 2303
28. Eurachem/Citac Guide, Quantifying the Uncertainty in Analytical Measurement, 2nd ed., 2000.
29. EA-4/16, EA Guidelines on the Expression of Uncertainty in Quantitative Testing, 2004, http://www.european-accreditation.org.